|
CA2516320C
(en)
*
|
2003-02-18 |
2015-05-26 |
Kevin Slawin |
Induced activation in dendritic cells
|
|
JP2007517550A
(ja)
|
2004-01-02 |
2007-07-05 |
アドヴァンスド カーディオヴァスキュラー システムズ， インコーポレイテッド |
高比重リポ蛋白をコーティングした医療デバイス
|
|
US8691210B2
(en)
*
|
2006-10-19 |
2014-04-08 |
David M Spencer |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
|
|
AU2009292996B2
(en)
|
2008-09-22 |
2015-04-23 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
|
|
JP5975983B2
(ja)
*
|
2010-04-16 |
2016-08-23 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
固形腫瘍を処置するための方法
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
US9750789B2
(en)
*
|
2011-02-18 |
2017-09-05 |
The Trustees Of Columbia University In The City Of New York |
Use of matrix metalloproteinase inhibitors to treat tuberculosis
|
|
HRP20250164T1
(hr)
|
2011-07-22 |
2025-04-11 |
Csl Behring Gmbh |
Inhibitorna monoklonska antitijela protiv faktora xii/xiia i njihove uporabe
|
|
MX367743B
(es)
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
US9220759B2
(en)
*
|
2012-02-23 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
|
|
US9220584B2
(en)
|
2012-03-30 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a stent and locally administered adjunctive therapy
|
|
CN105007939B
(zh)
|
2012-10-05 |
2018-10-19 |
卡德门企业有限公司 |
人抗vegfr-2/kdr抗体
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
IL241552B2
(en)
|
2013-03-14 |
2023-09-01 |
Contrafect Corp |
Preparation and methods based on neutralizing antibodies administered intranasally for increased therapeutic efficacy
|
|
CA2905352A1
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
EP3569253A1
(en)
|
2013-06-05 |
2019-11-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
TWI714869B
(zh)
|
2013-08-05 |
2021-01-01 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
|
|
ES2900004T3
(es)
|
2013-08-05 |
2022-03-15 |
Immatics Biotechnologies Gmbh |
Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (NSCLC)
|
|
AU2015214146B2
(en)
|
2014-02-04 |
2020-09-17 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
EP3104866A4
(en)
|
2014-02-14 |
2017-08-02 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating t cells using an inducible chimeric polypeptide
|
|
EP2907512A1
(en)
|
2014-02-14 |
2015-08-19 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Inhibitors of MMP-12 as antiviral Agents
|
|
AU2015244025B2
(en)
|
2014-04-08 |
2019-03-21 |
Boston Pharmaceuticals Inc. |
Binding molecules specific for IL-21 and uses thereof
|
|
AU2015312117A1
(en)
|
2014-09-02 |
2017-03-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by Myd88 and CD40 polypeptides
|
|
WO2016071758A1
(en)
|
2014-11-03 |
2016-05-12 |
Leiden University Medical Center |
T cell receptors directed against bob1 and uses thereof
|
|
CN110922481A
(zh)
|
2015-09-24 |
2020-03-27 |
第一三共株式会社 |
抗garp抗体
|
|
EP3410849B1
(en)
*
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
JP2018105726A
(ja)
*
|
2016-12-27 |
2018-07-05 |
株式会社国際電気通信基礎技術研究所 |
心筋梗塞、認知症、および腫瘍からなる群から選択される一種を予防、または治療するための有効成分の候補物質のスクリーニング装置、スクリーニングプログラム、およびスクリーニング方法
|
|
PE20250933A1
(es)
|
2017-03-14 |
2025-04-02 |
Five Prime Therapeutics Inc |
Anticuerpos de union a vista a ph acido
|
|
JP7234142B2
(ja)
|
2017-06-02 |
2023-03-07 |
ファイザー・インク |
Ｆｌｔ３に特異的な抗体およびその使用
|
|
US12140526B2
(en)
*
|
2018-02-28 |
2024-11-12 |
Juno Therapeutics, Inc. |
Methods for detecting particles present in a cell composition
|
|
SG11202008593PA
(en)
|
2018-03-21 |
2020-10-29 |
Five Prime Therapeutics Inc |
ANTIBODIES BINDING TO VISTA AT ACIDIC pH
|
|
AU2019301120A1
(en)
|
2018-07-11 |
2021-02-25 |
Bristol-Myers Squibb Company |
Antibodies binding to VISTA at acidic pH
|
|
US11332546B2
(en)
*
|
2019-05-21 |
2022-05-17 |
The Regents Of The University Of California |
Protease inhibitory antibodies and methods of use thereof
|
|
WO2021222595A2
(en)
*
|
2020-04-30 |
2021-11-04 |
Virtuoso Binco, Inc. |
Multispecific antibodies targeting cd38 and epcam and uses thereof
|
|
WO2021229306A2
(en)
*
|
2020-05-12 |
2021-11-18 |
Virtuoso Binco,Inc. |
Multispecific antibodies targeting cd38 and bcma and uses thereof
|
|
KR20230083288A
(ko)
*
|
2020-09-09 |
2023-06-09 |
이노벤트 바이오로직스 (쑤저우) 컴퍼니, 리미티드 |
코로나바이러스 스파이크 단백질에 대한 단일클론 항체, 및 이의 용도
|
|
WO2022266039A1
(en)
*
|
2021-06-16 |
2022-12-22 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Systems and methods for monitoring and treating stroke
|
|
JPWO2024090571A1
(enExample)
*
|
2022-10-28 |
2024-05-02 |
|
|
|
CN118530365B
(zh)
*
|
2024-06-18 |
2025-03-11 |
辽宁得康药业集团有限公司 |
特异性检测mmp12蛋白的单克隆抗体及其应用
|